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Escherichia coliShiga toxin (STx) belongs to the AB5 toxin family and is transiently localized in the periplasm before secretion
into the extracellular milieu. While producing outer membrane vesicles (OMVs) containing only A subunit of
the toxin (STxA), we created speciﬁc STx1B- and STx2B-deﬁcient mutants of E. coli O157:H7. Surprisingly,
STxA subunit was absent in the OMVs and periplasm of the STxB-deﬁcient mutants. In parallel, the A subunit
of heat-labile toxin (LT) of enterotoxigenic E. coli (ETEC) was absent in the periplasm of the LT-B-deﬁcient
mutant, suggesting that instability of toxin A subunit in the absence of the B subunit is a common phe-
nomenon in the AB5 bacterial toxins. Moreover, STx2A was barely detectable in the periplasm of E. coli JM109
when stx2A was overexpressed alone, while it was stably present when stxB was co-expressed. Compared
with STx2 holotoxin, puriﬁed STx2Awas degraded rapidly by periplasmic proteases when assessed for in vitro
proteolytic susceptibility, suggesting that the B subunit contributes to stability of the toxin A subunit in the
periplasm. We propose a novel role for toxin B subunits of AB5 toxins in protection of the A subunit from
proteolysis during holotoxin assembly in the periplasm.10; fax: +1 905 522 9033.
: +82 43 240 6309.
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Shiga toxin (STx) elaborated by E. coli O157:H7 is a typical AB5
exotoxin consisting of an A subunit and ﬁve identical B subunits [1–3].
The catalytic A subunit of STx (STxA; ~32 kDa protein) shows a ribo-
somal RNA (rRNA) N-glycosidase activity that speciﬁcally cleaves a
conserved adenine base of 28S rRNA of the 60S ribosomal subunit,
which eventually blocks protein synthesis and causes cell death [4].
The STxB subunit (~7.7 kDa protein) binds speciﬁcally to the host cell
membrane-anchored globotriaosylceramide (Gb3) receptor [5],
thereby mediating subsequent internalization of the toxin [3]. In the
absence of STxA, STxB can associate in a ring-like pentameric struc-
ture in the periplasm and can be substantially entrapped into OMVs
for extracellular secretion [6,7]. In general, STx toxins can be classiﬁed
into two types: STx1 (also known as VT1 for verotoxin or SLT-I for
Shiga-like toxin) and STx2 (also known as VT2 or SLT-II). STx1 is
nearly identical to the Shiga toxin of Shigella dysenteriae serotype 1,
differing only by one amino acid (AA), but shares overall 56% identity
with the AA sequence of STx2 types [1,8]. The Sakai strain of E. coliO157:H7 is capable of producing both STx1 and STx2, which are
encoded by stx1 and stx2 operons (stx1AB and stx2AB), respectively
[8]. STxs are believed to play a key role in the pathogenesis of hemo-
lytic uremic syndrome (HUS) [9]. However, effective prevention and
therapeutic interventions against the O157 infection and its sequela
HUS are yet to be developed.
Heat-labile toxin (LT) of enterotoxigenic E. coli (ETEC), the caus-
ative agent of traveler's diarrhea, also belongs to the AB5 toxin family.
Like STx, LT, encoded by a two-gene operon (lt-AB), is exported in a
Sec-dependent manner to the periplasm where holotoxin assembly
occurs with one catalytic A subunit (LT-A; ~28 kDa) and a homo-
pentamer of B subunits (LT-B; 11.6 kDa) [10,11]. Extracellular export
of LT across the outer membrane (OM) takes place via a speciﬁc type II
secretion system (T2SS) encoded by a gene cluster comprising gspC
to gspM [11]. However, no speciﬁc T2SS has been identiﬁed for the
extracellular secretion of STx from Shiga toxin-producing E. coli
(STEC). Thus, OMVs are likely utilized as non-speciﬁc extracellular
secretion vehicles for exporting STx accumulated in the periplasm of
STEC lacking the specialized toxin secretion system [12,13]. Consis-
tently, STx holotoxins and STxB pentamers were known to be largely
enclosed within OMVs [7,14]. Although LT is secreted by the speciﬁc
T2SS, approximately 95% of LT is still associatedwith the OMV because
the extracellular LT is able to bind to sugar residues in lipopolysac-
charide (LPS) on the surface of ETEC [15,16].
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O157E. coliwith theaimof generating low-endotoxic andSTxA-deﬁcient
OMVs that could be useful as vaccine vehicles. Next, we tried to produce
OMVs of O157 E. coli containing STxA uncoupled with STxB by creating
an internal deletion in the stxB gene. However, we found that the STxA
could hardly exist as a free form in the periplasm, which prevents
secretion of the free A subunit via OMVs. Collectively, in this study, we
have shown that periplasmic expression and subsequent extracellular
secretion of STxA-subunit alone is impossible without assistance by
STxB.Ourﬁndings reveal a novel role for the B subunit in stabilizing theA
subunit during AB5 toxin assembly in the periplasm. A chaperone-like
role for the toxin B subunit in the periplasm is thus proposed.
2. Materials and methods
Bacterial strains and plasmids used in this study are listed in
Table 1.
2.1. Creation of stx and degP mutants of E. coli O157:H7
E. coli O157:H7 strain Sakai [8] and its derivative Sakai-DM [17]
possessing less-endotoxic LPS (due to lack of MsbB myristoylation in
lipid A biosynthesis) were used as parental strains for creation of site-
speciﬁc mutations by using an allelic exchange procedure assisted by
the Red recombinase carried in pKD46, as described previously
[7,17,18]. In addition to pKD46, plasmid pKD3was used commonly for
construction of mutated alleles containing the chloramphenicol (Cm)-
cassette and pCP20 was used for excision of the Cm-cassette from the
resulting chromosomal mutant [18]. Transformants were plated in
Luria-Bertani (LB) agar, containing the appropriate antibiotics (Cm:
20 μg/ml, ampicillin (Amp): 100 μg/ml), and potential mutants were
conﬁrmed by a genomic PCR and DNA sequence analysis.
As E. coli O157:H7 Sakai strain possesses two stx operons, single
Δstx1B or Δstx2B mutant and the combined Δstx1B/Δstx2B double
mutant were created with targeting DNA template constructed in
pUC18-based recombinant plasmids pSTx1B::Cm and pSTx2B::Cm
(Table 1). Construction of those template plasmids (pSTx1B::Cm and
pSTx2B::Cm) was started by cloning of intact DNA fragments con-
taining stx1B and stx2B genes, then an inverse PCR was conducted toTable 1
Bacterial strains and plasmids used in this study.
Strains/plasmids Property
E. coli O157:H7 strain Sakai Wild type
Sakai-DM ΔmsbB1/msbB2 mutant of wild type
DM/Δstx1B Δstx1B mutant of Sakai-DM
DM/Δstx1B/stx2B Δstx1B/stx2B::Cm mutant of Sakai-D
DM/Δstx2A::Cm Δstx2A::Cm mutant of Sakai-DM
WT/Δstx1B Δstx1B mutant of Sakai wild type (W
WT/Δstx2B Δstx2B mutant of Sakai-WT
WT/Δstx2B/ΔdegP ΔdegP::Cm mutant of Sakai-WT/Δst
ETEC H10407 A reference strain of enterotoxigeni
ETEC/dLT-B Δlt-B::Cm mutant of ETEC H10407
E. coli JM109 endA1 gyrA96 thi hsdR17 supE44 relA
pKD46 A tS-plasmid encoding arabinose-in
pKD3 A template plasmid carrying the FR
pCP20 A tS-plasmid encoding the FLP reco
pSTx1B::Cm pUC18-based recombinant plasmid
pSTx2B::Cm pUC18-based recombinant plasmid
pDegP::Cm pUC18-based recombinant plasmid
pUC18 General cloning vector (AmpR)
pACYC184 General cloning vector (CmR), p15A
pAY-stx1B pACYC184-based recombinant plasm
pAY-stx2B pACYC184-based recombinant plasm
pBAD24 An arabinose-inducible expression v
pBAD-stx2A pBAD24-based recombinant plasmi
pBAD-stx2AB pBAD24-based recombinant plasmi
pBAD-stx2A1 pBAD24-based recombinant plasmiremove internal 180-bp DNA fragments from each ORF. The primers
for inverse PCR are as follows; the forward primer (Fw1B-Kpn):
CTGTCATAATGGTACCGGGATTCAGCGAAG and the reverse primer
(Re1B-Sal): TCAGGCGTCGACAGCGCACTTGCTG for stx1B, and the for-
ward primer (Fw2B-SacI): CCTGTGAATCAGAGCTCCGGATTTGCT and
the reverse primer (Re2B-Sal): GCACAATCCGTCGACATTGCATTAACAG
for stx2B, respectively. To incorporate the Cm-cassette (from pKD3) into
the deleted DNA regions of the two stxB ORFs, the inverse PCR products
weredigestedwith restriction enzymes recognizing theprimer sequence
underlined, then the Cm-cassette DNAwas inserted into the stxB alleles.
Similarly, an inverse PCR strategywas employed for construction of
ΔdegP::Cm allele in pUC18-based pDegP::Cm vector, with a view to
creatingWT/Δstx2B/ΔdegP::Cmmutant (Table 1). The inverse PCRwas
conducted with a primer set; the forward (Deg-SalF): CGGGTGAT-
GTGTCGACCTCACTGAAC and the reverse (Deg-KpnR): GACCAAA-
CGGGGTACCAATCGCTAC. Then, the Cm-cassette was inserted into
the SalI-KpnI sites generated by the inverse PCR primers underlined.
2.2. Creation of Δlt-B::Cm mutant of ETEC H10407
An allelic exchange approach was employed to make a mutation
in the chromosome of ETEC H10407 carrying pKD46, by using the
mutated allele constructed in the template plasmid. Construction of
the Δlt-B::Cm allele was started by cloning of DNA fragment (~834-
bp) for the region of lt-AB operon. Then, an inverse PCR was carried
out with primers of LTB-BamF (CTATCATATACGGATCCGATGGCAGG)
and LTB-SalR (GAGAGGATAGTCGACGCCGTAAATAA) to delete internal
120-bp DNA and to generate the restriction enzyme sites incorporated
in the primers underlined. The Cm-cassette DNA digested with SalI-
BamHI at both ends was then inserted into the deleted region of the lt-
B allele. Subsequently, the Δlt-B::Cm allele was introduced into ETEC
H10407 carrying pKD46 by electroporation to create the Δlt-B::Cm
mutant of ETEC H10407, which was designated ETEC/dLT-B (Table 1).
2.3. Cloning and expression of stx2 genes
For expressions of stx2A and stx2AB operon DNA in JM109, DNA
fragments encoding stx2A and stx2AB operon were cloned into pBAD24
digested with KpnI and SphI, respectively. High-ﬁdelity PCRwas carriedSource/Refs.
[8]
Sakai strain This study
This study
M This study
[7]
T) This study
This study
x2B This study
c E. coli (LT+) Lab collection
This study
1 traD36 Δ(lac-proAB)/F′(proAB lacIqZ M15) Lab collection
ducible λ-Red recombinase (AmpR) [18]
T-Cm-FRT cassette (CmR) [18]
mbinase (AmpR/CmR) [18]
carrying the Δstx1B::Cm allele (CmR/AmpR) This study
carrying the Δstx2B::Cm allele (CmR/AmpR) This study
carrying the ΔdegP::Cm allele (CmR/AmpR) This study
Lab collection
(rep) origin Lab collection
id carrying the stx1B gene (CmR) This study
id carrying the stx2B gene (CmR) This study
ector (AmpR), pBR322 (pMB1 rep) origin [23]
d carrying the stx2A gene (AmpR) This study
d carrying the stx2AB operon (AmpR) This study
d carrying the stx2A1 allele (AmpR) This study
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and stx2AB inserts. An approximately 994-bp amplicon of stx2A was
generated by PCR with primers VT2-A2-KpnF (GTATATGGTACCGTGTA-
TATTATTTAAATGG) and VT2-A2-SphR (CCATAAAGCATGCTTCTT-
CATGCTTAACTCC), and ~1280-bp amplicon of stx2AB operon DNA was
obtained from PCR with the common forward primer (VT2-A2-KpnF)
and a new reverse primer VT2B-SphR (ACACTTGTTACCCGCATGCCAC-
GAATCAGG). The resulting pBAD24-derivedplasmids carrying the stx2A
and stx2AB operon DNA were named pBAD-stx2A and pBAD-stx2AB,
respectively.
Similarly, for expression of stx2A1 DNA encoding the A1-fragment
of STx2A (processed residues from Arg1 to Arg250) in JM109, the
insert DNA was cloned into pBAD24 digested with KpnI and SphI. An
approximately 835-bp amplicon of stx2A1 DNA was generated by PCR
with primers VT2-A2-KpnF (common forward primer) and VT2-A1-
SphR (CTCTTCATTCACGCATGCTCAGCGAACAGAACGCGC) carrying the
restriction site underlined. The resulting pBAD24-derived plasmids
carrying the stx2A1 DNA was named pBAD-stx2A1.
E. coli JM109 transformed with the pBAD24-based clone (pBAD-
stx2A, pBAD-stx2AB, and pBAD-stx2A1) was cultured in LB-Amp broth
until A600 (O.D.) reached 0.7, then 0.2% (ﬁnal conc.) of L-arabinose was
added to induce expression of the cloned DNA, and the culture was
further incubated for 3 h in a shaker at 37 °C.
2.4. Complementation of STx2A instability with the cloned stxB genes
For the complementation of JM109/pBAD-stx2A, pACYC184-derived
plasmids pAY-stx1B and pAY-stx2B were constructed (Table 1). Brieﬂy,
DNA fragments encoding stx1B and stx2B gene were ampliﬁed by PCR
with genomic DNA template of Sakai O157 E. coli. An approximately
330-bp amplicon of stx1B was generated by PCR with primers ST1B-
BamF (TCTGGATCCGCAGAACTATTAGCAG) and ST1B-SalR
(CCTGCTATTTGTCGACTGAGCTATTC), and ~320-bp amplicon of stx2B
DNA was obtained from PCR with primers ST2B-BamF (GGGTAAA-
TAAAGGATCCGTTAAGCATG) and ST2B-SalR (CACATACCACGAAGTC-
GACGGTTATGCCTC). The stxB DNA digested with BamHI and SalI was
then inserted into pACYC184 digested with same restriction enzymes.
The resulting stxB clones (named pAY-stx1B and pAY-stx2B) were
designed to be expressed constitutively under the pACYC184-based
promoter in the JM109/pBAD-stx2A host strain. Similarly, for comple-
mentation of JM109/pBAD-stx2A1, pAY-stx2B was introduced to be
expressed constitutively under the pACYC184-based promoter in the
JM109/pBAD-stx2A1 strain.
2.5. Preparation of periplasmic protein extracts (PPE) and OMVs
The PPE sample was prepared as described in the manual for the
PeriPrepsTM Periplasting kit (Epicentre®). Brieﬂy, bacterial cells
grown overnight were centrifuged (12,000×g for 10 min) to discard
the culture supernatant. The pellet was resuspended in 0.5 ml of
periplasting buffer containing lysozyme and the sample was incubat-
ed on ice for 5 min. After osmotic shock for 5 min by adding 0.5 ml of
ice-cold puriﬁed water, the sample was centrifuged at 12,000×g
for 5 min to remove the spheroplasts and intact cells from the
supernatant. The supernatant recovered was used as PPE.
OMVs were prepared as described previously [17] with slight
modiﬁcations. Brieﬂy, E. coli O157:H7 and its isogenic mutants were
inoculated into 500 ml of LB broth and cultured overnight at 37 °C in a
shaker. The bacteria were then pelleted by centrifugation (12,000×g)
for 10 min at 4 °C. The resulting supernatant was recovered and
further passed through a 0.22 μm pore-size ﬁlter. The OMVs were
harvested by concentrating the ﬁlterates by using QuixStandTM ultra-
ﬁltration system (GE Healthcare) equipped with a membrane car-
tridge (~100 kDa cutoff size). Then, OMVs in the concentrated sample
were collected in the pellet by ultracentrifugation at 100,000×g
for 2 h at 4 °C. The crude OMV-pellet was resuspended in 3 ml ofphosphate buffered saline (PBS, pH7.4) for further OMV puriﬁcation
using sucrose-gradient ultracentrifugation.
2.6. Separation of STx2 subunits and proteolytic susceptibility of STx2A
The A and B subunits of puriﬁed STx2 holotoxin (Toxin Technology
Inc., USA) were separated by incubation of the toxin in 1 ml of a
subunit dissociating solution (6 M urea, 0.1 M NaCl, 0.1 M propionic
acid, pH4.0) without stirring at 4 °C for 1 h, as described previously
[19]. Then, the toxin preparation was subjected to FPLC (BioRad,
Hercules, CA) equipped with SuperdexTM 75 column (GE Healthcare,
Uppsala, Sweden) to fractionate the A and B subunits. The pooled
fractions corresponding to the holotoxin and the STx2A subunit were
then freeze-dried and the toxin preparations were suspended in PBS
(pH7.4) to be tested for proteolytic susceptibility. Subsequently, the
holotoxin and the free STx2A subunit were mixed with the PPE
sample of E. coli JM109, which was used as a source of periplasmic
proteases. After the co-incubation for 5 min at 37 °C, the sample was
immediately mixed with SDS-sample buffer prior to boiling for 5 min
at 100 °C.
2.7. Immuno-blot (IB) analysis
Protein concentrations of PPE and OMV samples were estimated
by using the BCA protein assay kit (Pierce®) and analyzed by SDS-
PAGE (15% gel). The separated protein bands were blotted onto
nitrocellulose membrane (Invitrogen, USA) for IB analysis. Monoclo-
nal antibodies (mAbs) against bacterial alkaline phosphatase (BAP-
77), STx1B (13C4), STx2A (11E10), and LT-A were purchased from
various commercial sources. The peroxidase-conjugated rabbit anti-
mouse IgG (Sigma, USA) was used as secondary antibody for the
enhanced chemiluminescence (ECL) detection of the target proteins.
2.8. Negative staining for transmission electron microscopy (TEM)
To visualize the OMVs, samples were applied to a formvar-coated
grid by adsorption. The grid was then stained with 2% uranyl acetate,
blotted with ﬁlter paper, and then air dried. The samples were
examined under a CM20 TEM (Philips, the Netherlands).
3. Results
3.1. Absence of STxA in the periplasm of STxB-deﬁcient mutants
It was previously reported that OMVs of Sakai O157 E. coli carry the
STx toxins [14], as well as the STxB pentamers in the case of STxA-
deﬁcient mutant [7]. In an initial effort to produce the OMVs con-
taining free STxA (uncoupled from STxB), we created a Δstx1B or
Δstx2B mutant and the double stxB deletion mutant in Sakai O157
E. coli. Subsequently, OMVs secreted from the stxB mutants were
isolated and identiﬁed by TEM visualization (Fig. 1A). A TEM image of
the OMVs from the stxB mutants showed a typical morphology and
sizes ranging 20–100 nm in diameter (Fig. 1A), which was not
signiﬁcantly different from those observed previously in E. coli O157:
H7 [7,17]. To test whether STxA is enclosed within the OMVs, im-
munoblotting (IB) was performed with anti-STx2A mAb available
commercially (clone 11E10, SantaCruz Biotech). Normally STx2A
subunit was present in the PPE and OMV samples of the parental
(control) Sakai O157 strains (Fig. 1B). However, STx2A was only
identiﬁed in the STx1B-deﬁcient mutants (lanes 1 and 3, Fig. 1C) but
absent in the STx2B-deﬁcient mutants (lanes 2 and 4, Fig. 1C). These
results suggest that the toxin A subunit can exist in the periplasm of
Sakai O157 E. coli, only when coupled to its cognate B-pentamer.
Consequently, STx2A was not detected in the OMVs of DM/Δstx1B/
Δstx2B mutant (lane 2, Fig. 1D), compared to the parental strain
as positive control (lane 1). These results clearly showed that
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(A) The STx2A subunit was detected in the PPE samples of STEC O157 Sakai derivatives.
STx2A band was present only in the wild type strain (lane 1) but absent in the both
Δstx2B and Δstx2B/ΔdegP::Cm mutants (lanes 2 and 3, respectively). Inactivation of
degP in the Δstx2Bmutant background did not rescue the STx2A band in the periplasm
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deﬁcient mutant (ETEC/dLT-B) were analyzed by using anti-LT-A mAb (Abcam). As
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compared to wild type strain (lane 1).
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due to lack of commercially available anti-STx1A mAb) can be
prevented in the O157 E. coli by deﬁciency of the toxin B subunit.
Interestingly, STx2A was not detected by IB in the periplasm (lanes
2 and 4, Fig. 1C), in spite of the presence of STx1B subunit which
remained intact in the Δstx2B mutant (lane 1, Fig. 1E).
3.2. Neither transcriptional impairment of the stxA gene nor DegP
protease activity was involved in the instability of STxA in the periplasm
To exclude the possibility that instability of STxA in the periplasm
of stxB mutants (Fig. 1C) might be due to impairment of stxA gene
transcription, a reverse transcriptase (RT)-PCR was conducted to
verify whether transcription of stxA genes can occur in the ΔstxB
mutants of E. coli O157:H7. RT-PCR showed that stxA gene transcrip-
tion was not altered in the ΔstxB mutants, compared with wild type
strain (data not shown). Accordingly, it is unlikely that the absence of
STxA in the periplasm is simply associated with the impaired stxA
gene transcriptionwhichmight occur due to the stxB genemutation in
the stxAB operon.
Next, we tested whether DegP would be involved in the possible
degradation of the orphan STxA subunit in the STxB-deﬁcient mutant,
since DegP has been known to play an important role in the periplasm
as a protease, with a broad spectrum of substrates including peri-
plasmic andmisfolded OMproteins [20,21]. In the IB analysis (Fig. 2A),
however, the STx2Awas still not rescued in the PPE prepared from the
ΔdegP::Cm mutant of WT/Δstx2B strain (lane 3, Fig. 2A), compared to
the positive (lane 1) and negative (lane 2) controls. The fact that DegP
inactivation (lane 3, Fig. 2A) did not rescue the STx2A band in the
Δstx2B background may imply that DegP is not involved in the in-
stability of STx2A in the periplasm.
3.3. Absence of LT-A in the periplasm of LT-B-deﬁcient mutant
Since we have shown that STxA is unable to exist in the periplasm
in the absence of STxB, we tried to test the possibility that such
instability of toxin A subunit in the absence of the B subunitmight be a
common phenomenon, at least in the context of the AB5 enterotoxins.
Accordingly, a Δlt-B::Cm mutant of ETEC H10407 was created for
parallel comparison with the STx case. As shown in Fig. 2B, the LT-A
subunit (~28 kDa band) was absent in the PPE sample of the LT-B-deﬁcient mutant (ETEC/dLT-B) when analyzed by IB with anti-LT-A
mAb. Therefore, it is likely that the LT-B subunit also could provide a
protective role for the LT-A in the periplasm. Because of the similar
nature of cholera toxin (CT) and LT [22], one can speculate that CT-A
subunit is likely to be unstable in the periplasm of CT-B-deﬁcient
mutant of Vibrio cholera. However, we did not test this possibility in
the present study.
3.4. Complementation of STx2A instability in the periplasm of non-STEC
E. coli
To assess the STx2A instability in the periplasm of E. coli JM109
strain, a non-STEC background, recombinant plasmids carrying the
stx2A and stx2AB operon DNA (named pBAD-stx2A and pBAD-stx2AB,
respectively) were constructed on the basis of pBAD24 vector [23],
and expression of the cloned DNA was induced by L-arabinose ad-
dition into the culture of JM109 transformed with the plasmid. Then,
IB analysis was carried out with the PPE samples prepared from the
JM109 transformants. Consistently, STx2A band was detected in the
pBAD-stx2AB transformant (lane 2, Fig. 3A) but not in the case with
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Fig. 3. IB analysis of PPE samples of JM109 transformants. (A) PPE samples prepared
from the JM109 cells harboring the respective pBAD-stx2A and pBAD-stx2AB clone were
immunoblotted with anti-STx2A mAb. (B) For the complementation of JM109/pBAD-
stx2A, plasmid pAY-stx1B or pAY-stx2B was introduced. STx2A band was strongly
detected in the complementation with either pAY-stx2B or pAY-stx1B, whereas STx2A
subunit overexpressed in the JM109/pBAD-stx2A strain (lane 1) was hardly detectable
by IB with anti-STx2A mAb. (C) IB was performed to see whether A1 fragment of STx2A
can exist alone in the periplasm of JM109. PPE of JM109/pBAD-stx2A1 contained the A1
fragment, albeit at reduced amount (lane 4) compared to the A1 fragment
complemented with STx2B (lane 5).
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subunit for the periplasmic presence of STx2A in non-STEC E. coli. In
order for the complementation of JM109/pBAD-stx2A, pACYC184-
derived plasmids pAY-stx1B and pAY-stx2Bwere constructed for their
carriage of the stx1B and stx2B gene, respectively. The stxB cloneswere
designed to be expressed constitutively under the pACYC184-based
promoter in the JM109/pBAD-stx2A host strain. Interestingly, the
arabinose-induced STx2A band was strongly detected in the comple-
mentation with either pAY-stx2B or pAY-stx1B (Fig. 3B), whereas the
STx2A expressed in the JM109/pBAD-stx2A control strain was hardly
detectable by IB (lane 1, Fig. 3B). These results reconﬁrmed that STxB
could play a crucial role for maintaining the stability of STxA during
the holotoxin formation in the periplasm.
The crystal structure of the holotoxin [2] reveals that the A2
fragment of STx2A is crucial for interactions with residues in the
central pore of the B-pentamer. The pBAD-stx2A1 clone was thereby
constructed to test the assumption that STx2A1 lacking the A2 tail
(residues from Ala251 to Lys297) can be expressed independently of
the B-pentamer. Interestingly, the A1 fragment (residues from Arg1 to
Arg250) can exist alone in the periplasm of JM109, albeit at reduced
amount (lane 4, Fig. 3C) when compared to the A1 fragment
complemented with STx2B (lane 5, Fig. 3C).
3.5. Instability of STx2A caused by STx2B deﬁciency is associated with
increased proteolytic susceptibility
Next, proteolytic susceptibility to periplasmic proteases was
assessed with the free STx2A separated from the puriﬁed holotoxin
(Toxin Technology Inc., USA), under the assumption that the toxin B
subunit may play a role in the protection of the A subunit in the
periplasm. Separation of STx2 subunits was conducted as describedpreviously [19]. The elution peak for STx2 holotoxin was evident in
faction number 11 as shown in the panel A of Fig. 4 (indicated by AB5).
The inset showed STx2-A and -B subunits separated by SDS-PAGE. The
peak for free STx2A (dissociated) appearing around fraction number
14 was collected by HPLC fractionation (panel B, Fig. 4). Accordingly,
the free A subunit obtained (Fig. 4B) and STx2 holotoxin were tested
for in vitro proteolytic susceptibility toward periplasmic proteases
that were provided by the PPE of JM109. A densitometry analysis of
the IB results (Fig. 4C) revealed that intensity of STx2A band was 2.2-
fold reduced after 5 min co-incubation with the PPE (10 μg) of
JM109 at 37 °C. The STx2A band was not detected by IB after 10 min
incubation with the source of periplasmic proteases although the
holotoxin remained intact after the co-incubation. These results
strongly support that the instability of toxin A subunit caused by
deﬁciency of the B subunit might be due to increased susceptibility to
the periplasmic proteases.
4. Discussion
Previously, role(s) of toxin B subunits of AB5 enterotoxins have been
largely focused on the ability of binding to cellular receptors [19,24,25],
which triggers uptake of the toxin by endocytosis. Because the target
substrate of STxA activity (rRNAN-glycosidase) is located in the cellular
cytosolic compartment, the toxin has to be delivered to the ribosomal
site via retrograde intracellular trafﬁcking after internalization [3].
According to thedetailed structure of STx2 [2], theA2 fragment serves as
a linker domain, tethering the enzymatic A1 fragment to the B-
pentamer, as shown in Fig. 5A. The 32 kDa STx2A subunit, subdivided as
A1 (yellow) and A2 (magenta) fragments, is known to be non-
covalently associated with ﬁve STx2B (7.7-kDa) subunits (green). In
the absence of the B-pentamer (panel B), the A2-domain (magenta) of
STx2A would be then exposed to periplasmic proteases. However, it is
uncertain that the C-terminal A2-tail (magenta) of STx2A can be folded
correctly or not in the absence of STx2B subunits.
In the case of STx2B deﬁciency, in this study, the free STx2A then
exposes the A2 fragment which remains uncovered in the periplasm,
otherwise the alpha-helical portion of the A2 fragment can be
securely shielded within the central pore of the B-pentamer (Fig. 5).
Also, the upper region above the pore-penetrating alpha-helix portion
of the A2 fragment might be inaccessible because of tight association
at the interface between the A1-fragment and the B-pentamer.
Although the toxin B-subunit forms a stable pentameric struc-
ture [7,25,26], the toxin A subunit alone was highly unstable in the
periplasm as shown in this study. Therefore, it was of interest to
determine whether site-speciﬁc deletion of the A2 tail in the STxA
could stabilize the truncated A subunit in the periplasm in the absence
of STxB. As shown in Fig. 3C, the truncated STx2A protein lacking the
A2 tail can exist alone in the periplasm of JM109, albeit at reduced
amount (lane 4) compared to the A1 fragment complemented
with STx2B (lane 5). Interestingly, stability of the A1 fragment was
increased in the periplasm when complemented with STx2B (lane 5),
indicating that the A1 fragment can still interact with the B-pentamer.
These results suggest that the A2 fragment in the absence of the B-
pentamer might be partially misfolded and thus slowly targeted
towards the periplasmic proteases. However, the exposure of the A2
fragment in the absence of STxB (panel B, Fig. 5) appears to render the
A subunit highly susceptible to periplasmic proteases.
In vitro, STx holotoxin hybrids (for example; VT1A:VT2B and
VT2A:VT1B) can be assembled with the puriﬁed dissociated subunits
[19]. Although, STx2A:STx1B hybrid formation was identiﬁed in K-12
E. coli host carrying the plasmid clones, in vivo formation of STx1A:
STx2B hybrid was not detected in the previous reports [27,28].
Accordingly, formation of STx2A:STx1B hybrid can be possible in the
stx2B mutant of Sakai O157 stain in which stx2A and stx1B genes
remain intact. However, as shown in Fig. 1C, such a hetero-subunit
hybrid toxinwas not detected in the periplasm of Sakai O157mutants,
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Fig. 4. In vitro STx2A susceptibility to proteolytic degradation by periplasmic proteases. (A and B) The puriﬁed STx2 holotoxin (Toxin Technology Inc., USA) and the free STx2A
subunit fractionated by HPLC as described previously [19] were subjected to proteolytic susceptibility assay with the PPE from JM109. The inset (A) showed STx2-A and -B subunit
separated by SDS-PAGE. (C) Approximately half of the free STx2A (2.2-fold reduction in the band intensity) was degraded in 5 min co-incubation with the PPE (10 μg) from JM109 at
37 °C, while the holotoxin (5 μg) remained intact after the co-incubation with the source of periplasmic proteases.
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pAY-stx1B plasmid the STx2A was stably present in the periplasm
(Fig. 3B). Although the hybrid (STx2A:STx1B) toxin was not de-
tected in the Δstx2B mutant of Sakai O157 strain, it can be formed in
the JM109 host as inferred from the complementation experiment
(Fig. 3B). We reasoned that STx1B would have a higher likelihood to(A)           STx2 (1R4P)
Fig. 5. Ribbon structure of STx2 toxin. Structures of STx2 holotoxin (A) and STx2A (B) w
manipulation by using the PyMOL Molecular Graphics System, Version 1.3, Schrödinger, LLC
the panel A, is known to be non-covalently associated with ﬁve STx2B (7.7-kDa) subunits (g
would be then exposed to periplasmic proteases.combine with the STx1A rather than STx2A in the Δstx2B mutant, so
that the subsequent binding of STx1B to STx2A and its role proposed
for the protection of the A subunit from proteolysis (Fig. 4) are
unlikely in the case of Sakai Δstx2B mutant. It will be interesting to
test whether the STx2A:STx1B hybrid can be detected or not in the
Δstx2B/Δstx1A mutant of Sakai O157 E. coli.(B)           
ere obtained from the Protein Data Bank (accession code: 1R4P) and displayed after
. The 32 kDa STx2A subunit, subdivided as A1 (yellow) and A2 (magenta) fragments in
reen). In the absence of the B-pentamer (panel B), the A2-domain (magenta) of STx2A
2365S.-H. Kim et al. / Biochimica et Biophysica Acta 1808 (2011) 2359–2365In this study, we tried to understand why the toxin A subunits are
unable to exist alone in the periplasm of the B subunit-deﬁcient
mutants. One explanation is that susceptibility of the free A subunit
towards periplasmic proteaseswas increased, as shown in Fig. 4. In the
E. coli periplasm, a number of proteases have been identiﬁed including
DegP [29,30]. Since DegP is an important periplasmic protease with a
broad spectrum of substrates, including periplasmic and misfolded
OMproteins [20,21], we tested the possible involvement of DegP in the
instability of the free toxin A subunit. However, such instability of
toxin A subunit is not simply associated with DegP (Fig. 2A) or
impairment of stxA gene transcription in the stxB mutants. Further
study would be required to elucidate the mechanism underlying
proteolysis of the free A subunit in the periplasm and the exact role of
toxin B subunit involved in the stability of the A subunit during the
holotoxin assembly.
In conclusion, we have shown that the toxin B subunits (in both
STx and LT) are required for the stability of the A subunit during the
AB5 toxin assembly in the bacterial periplasm. To our best knowledge,
these observations would be the ﬁrst report showing that such
instability of toxin A subunit in the absence of its cognate B subunit is
a common phenomenon in the closely related AB5 bacterial toxins and
that the toxin B subunit plays an essential role in stabilizing the A
subunit during the AB5 toxin assembly in the bacterial periplasm.
Since the OMVs of STxB-deﬁcient mutants were not cytotoxic to Vero
cells (data not shown), target inactivation of the toxin B-subunit
would provide a new approach towards detoxiﬁcation of OMVs from
diverse pathogenic bacteria capable of producing AB5 toxins.
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